论文部分内容阅读
小儿急性淋巴细胞白血病 (ＡＬＬ)的疗效近 10多年来有了很大的提高 ,其 5年无病生存 (ＥＦＳ)率已达 80 %甚至更高。这主要是因为应用了以左旋门冬酰胺酶 (Ｌ ａｓｐａｒａｇｉ ｎａｓｅ ,Ｌ ａｓｐ)和蒽环类的抗癌药如柔红霉素 (ＤＮＲ)及去甲氧柔红霉素 (ＩＤ)为主的联合诱?
The efficacy of pediatric acute lymphoblastic leukemia (ALL) has been greatly improved over the past 10 years, with a 5-year disease-free survival (EFS) rate of 80% or more. This is mainly due to the application of anticancer drugs such as daunorubicin (DNR) and daunorubicin (ID) with Lasparaginase (L asp) and anthracyclines Joint lure?